Abstract:Objective. The diagnosis of persistent pulmonary hypertension (PPHN) can often be difficult to make, especially in a clinical setting in which pediatric echocardiography is not readily available. A noninvasive test that could differentiate PPHN from other cardiorespiratory disease would be very useful in the early management of the disease, because it would allow rapid identification of those infants at greatest risk of requiring the services of a level 3 nursery. Brain-type natriuretic peptide (BNP) is an endogenous peptide hormone secreted by the cardiac ventricles in response to increased wall stress and related ventricular filling pressures. The purpose of this study was to determine if BNP levels are elevated in newborns with PPHN and therefore may be used as a marker for differentiating PPHN from other forms of respiratory disease during the early newborn period. Method. We used a prospective cohort design with 3 groups. One group was diagnosed with PPHN by clinical and echocardiographic criteria (PPHN group: n = 15). The second group had been diagnosed with respiratory disease; however, PPHN had been ruled out by having no evidence of elevated pulmonary pressure by echocardiography (RD group: n = 17). The third group had no respiratory disease and was breathing room air (RA group: n = 15). BNP levels were measured with a point-of-care fluorescence immunoassay at various time intervals between birth and 150 hours of life. Results. There were no differences between groups for birth weight, gestational age, gender, race, Apgar scores at 1 minute, or age at time of initial blood sampling. Initial BNP levels (pg/mL) were elevated in the PPHN group relative to both the RA and RD groups (median [25%, 75%]: PPHN group = 1610 [1128, 1745]; RD group = 132 [76, 327]; RA group = 248 [127, 395]). There was no difference in the initial BNP level between the RA and RD groups. BNP levels remained elevated in the PPHN group over both groups for the first 4 days of life. BNP levels correlated with the gradient of the tricuspid regurgitation jet and with the ratio of tricuspid regurgitation jet gradient to mean blood pressure. BNP levels were not affected by administration of dopamine or dobutamine. BNP weakly correlated with the oxygenation index but not with the alveolar-arterial oxygenation gradient. Conclusions. Our findings indicate that BNP levels are elevated in infants with PPHN but not in infants with other forms of respiratory distress not associated with PPHN. Elevated BNP levels in term or near-term infants with respiratory distress should increase the suspicion of PPHN. Serial determination may also be helpful in monitoring the clinical course of such infants.

Altered metabolites in newborns with persistent pulmonary hypertension

[Screening for Fatty Acid Oxidation Disorders of Newborns in Zhejiang Province:Prevalence, Outcome and Follow-Up].

Polymorphisms in urea cycle enzyme genes are associated with persistent pulmonary hypertension of the newborn

Morbidity of Persistent Pulmonary Hypertension of the Newborn in the First Year of Life

Metagenomic Analysis of Gut Microbiome of Persistent Pulmonary Hypertension of the Newborn

Newborn screen metabolic panels reflect the impact of common disorders of pregnancy

Patient Characteristics in Persistent Pulmonary Hypertension of the Newborn

EPIDEMIOLOGIC ANTECEDENTS OF PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN

Metabonomics Reveals Metabolite Changes in Biliary Atresia Infants

Persistent Pulmonary Hypertension of the Newborn in Late Preterm and Term Infants in California

Defining the Typical Course of Persistent Pulmonary Hypertension of the Newborn: When to Think Beyond Reversible Causes

Identification of genetic factors underlying persistent pulmonary hypertension of newborns in a cohort of Chinese neonates

Identifying placental metabolic biomarkers of preterm birth using nuclear magnetic resonance of intact tissue samples

A comprehensive study of clinical biomarkers, use of inotropic medications and fluid resuscitation in newborns with persistent pulmonary hypertension

Correction: Investigating the Metabolic Model in Preterm Neonates by Tandem Mass Spectrometry: A Cohort Study

Novel Compound Heterozygous PKLR Mutation Induced Pyruvate Kinase Deficiency With Persistent Pulmonary Hypertension in a Neonate: A Case Report

Brain-Type Natriuretic Peptide in the Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn

Neonatal-Perinatal Risk Factors for the Development of Persistent Pulmonary Hypertension of the Newborn in Preterm Newborns

Metabolic Analysis of Infants with Bronchopulmonary Dysplasia under Early Nutrition Therapy: an Observational Cohort Study

Early metabolic markers as predictors of respiratory complications in preterm infants with bronchopulmonary dysplasia

Risk Factors for Persistent Pulmonary Hypertension of the Newborn